Company / Net Income
Amgen Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$7.7B
FY2025
5-year range
$4.1B / $7.7B
FY2021-FY2025
Trend
+88.5%
vs FY2024
Sector context
#7 of 214
Health Care
What the data says
Among 214 Health Care companies, Amgen is in the top 3% for net income. Net Income has fluctuated over the past 10 years, ranging from $2.0B in FY2017 to $8.4B in FY2018.
Based on SEC 10-K filings.
$7.7B in FY2025 with a 5-year CAGR of +1.2%. Top quartile in the Health Care sector.
Improved from $6.7B to $7.7B over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- +5.6%
- 5-Year CAGR
- +1.2%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 214This company $7.7B Sector average $443.1M
▼
+1640.4% above sector average
Key checks
Key Insights
- 5-year CAGR of +1.2%, indicating consistent growth.
- In FY2025, net income increased 88.5% year-over-year.
- Ranks #7 out of 214 companies in the Health Care sector.
- Peak net income was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.7B | +88.5% |
| FY2024 | $4.1B | -39.1% |
| FY2023 | $6.7B | +2.5% |
| FY2022 | $6.6B | +11.2% |
| FY2021 | $5.9B | -18.9% |
| FY2020 | $7.3B | -7.4% |
| FY2019 | $7.8B | -6.6% |
| FY2018 | $8.4B | +324.2% |
| FY2017 | $2.0B | -74.4% |
| FY2016 | $7.7B | +11.3% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026